Overview A Pharmacokinetic Study to Evaluate BBI-5000 Capsules and Food Effect in Healthy Adult Subjects Status: Completed Trial end date: 2015-12-01 Target enrollment: Participant gender: Summary To assess the pharmacokinetics of 3 doses and the food effect of a single high dose of BBI-5000 capsules in healthy adult subjects. Phase: Phase 1 Details Lead Sponsor: Brickell Biotech, Inc.